A phase I/II trial of induction chemotherapy plus gefitinib (Iressa) followed by concurrent chemotherapy, radiation therapy, and gefitinib (Iressa) for patients with locally advanced squamous carcinoma of the head and neck
Phase of Trial: Phase I/II
Latest Information Update: 24 Nov 2013
At a glance
- Drugs Carboplatin; Docetaxel; Fluorouracil; Gefitinib
- Indications Head and neck cancer
- Focus Therapeutic Use
- 22 Oct 2007 New trial centre added.
- 22 Feb 2006 New trial record.